Enhancement in liver SREBP-1c/PPAR-α ratio and steatosis in obese patients: Correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion

Angulo, 2002, Nonalcoholic fatty liver disease, New Engl. J. Med., 346, 1221, 10.1056/NEJMra011775

George, 2008, Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets, Mol. Pharm., 5, 49, 10.1021/mp700110z

Videla, 2006, Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease, Trends Mol. Med., 12, 555, 10.1016/j.molmed.2006.10.001

Nielsen, 2004, Splanchnic lipolysis in human obesity, J. Clin. Invest., 113, 1582, 10.1172/JCI21047

Fabbrini, 2008, Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease, Gastroenterology, 134, 424, 10.1053/j.gastro.2007.11.038

Araya, 2004, Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease, Clin. Sci., 106, 635, 10.1042/CS20030326

Elizondo, 2007, Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients, Obesity, 15, 24, 10.1038/oby.2007.518

Videla, 2004, Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients, Clin. Sci., 106, 261, 10.1042/CS20030285

Borkman, 1993, The relationship between insulin sensitivity and the fatty acid composition of phospholipids of skeletal muscle, N. Engl. J. Med., 328, 238, 10.1056/NEJM199301283280404

Lombardo, 2006, Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review, J. Nutr. Biochem., 17, 1, 10.1016/j.jnutbio.2005.08.002

Jump, 2005, Fatty acid regulation of hepatic gene transcription, J. Nutr., 135, 2503, 10.1093/jn/135.11.2503

Sampath, 2005, Polyunsaturated fatty acid regulation of genes of lipid metabolism, Annu. Rev. Nutr., 25, 317, 10.1146/annurev.nutr.25.051804.101917

Lindén, 2002, Influence of peroxisome proliferator-activated receptor α agonists on the intracellular turnover and secretion of apolipoprotein (apo) B-100 and apoB48, J. Biol. Chem., 277, 23044, 10.1074/jbc.M110416200

Kadowaki, 2005, Adiponectin and adiponectin receptors, Endocr. Rev., 26, 439, 10.1210/er.2005-0005

Matthews, 1985, Homeostasis model assessment: insulin resistance and β-cell function from fasting glucose and insulin concentration in man, Diabetologia, 28, 412, 10.1007/BF00280883

Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162, 156, 10.1016/0003-2697(87)90021-2

Ramakers, 2003, Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data, Neurosci. Lett., 339, 62, 10.1016/S0304-3940(02)01423-4

Dheda, 2004, Validation of housekeeping genes for normalizing RNA expression in real-time PCR, Biotechniques, 37, 112, 10.2144/04371RR03

Bligh, 1959, A rapid method of total lipid extraction, Can. J. Biochem. Physiol., 37, 911, 10.1139/o59-099

Schwarz, 2003, Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets, Am. J. Clin. Nutr., 77, 43, 10.1093/ajcn/77.1.43

Timlin, 2005, Temporal pattern of de novo lipogenesis in the postprandial state in health men, Am. J. Clin. Nutr., 81, 35, 10.1093/ajcn/81.1.35

Donnelly, 2005, Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J. Clin. Invest., 115, 1343, 10.1172/JCI23621

Tamura, 2005, Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease, J. Clin. Invest., 115, 1139, 10.1172/JCI24930

Sato, 2009, SREBPs: protein interaction and SREBPs, FEBS J., 276, 622, 10.1111/j.1742-4658.2008.06807.x

Palmer, 1998, Peroxisome proliferator activated receptor-α expression in human liver, Mol. Pharmacol., 53, 14, 10.1124/mol.53.1.14

Mukherjee, 1994, Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators, J. Steroid Biochem. Mol. Biol., 51, 157, 10.1016/0960-0760(94)90089-2

Reddy, 2004, Peroxisome proliferators and peroxisome proliferator-activated receptor α. Biotic and xenobiotic sensing, Am. J. Pathol., 164, 2305, 10.1016/S0002-9440(10)63787-X

Gervois, 1999, A truncated human peroxisome proliferator-activated receptor α splice variant with dominant negative activity, Mol. Endocrinol., 13, 1535

Ye, 2008, Regulation of PPARγ function by TNF-α, Biochem. Biophys. Res. Commun., 374, 405, 10.1016/j.bbrc.2008.07.068

Poniachik, 2006, Increased production of IL-1α and TNF-α in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease, Cytokine, 33, 252, 10.1016/j.cyto.2006.02.006

Murakami, 1999, Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha, Biochem. Biophys. Res. Commun., 260, 609, 10.1006/bbrc.1999.0951

Elizondo, 2008, Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease, Biol. Res., 41, 59, 10.4067/S0716-97602008000100008

Yamauchi, 2001, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nat. Med., 7, 941, 10.1038/90984

Kohjima, 2007, Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease, Int. J. Mol. Med., 20, 351

Nakamuta, 2008, The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease, Int. J. Mol. Med., 22, 663

Clarke, 2001, Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome, J. Nutr., 131, 1129, 10.1093/jn/131.4.1129

Capanni, 2006, Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study, Aliment. Pharmacol. Ther., 23, 1143, 10.1111/j.1365-2036.2006.02885.x

Videla, 2008, Oxidative stress and insulin resistance as interdependent pathogenic mechanisms in non-alcoholic fatty liver disease associated with obesity, 369

Ferré, 2007, SREBP-1c transcription factor and lipid homeostasis: clinical perspective, Horm. Res., 68, 72, 10.1159/000100426

Videla, 2009, Liver NF-κB and AP-1 DNA binding in obese patients, Obesity, 17, 973, 10.1038/oby.2008.601